Microbicides 2010 Conference: Poster and Presentations
Presentations
Printer friendly version (PDF)
Title |
Presenter |
Probiotics: the Potential for a Live Microbicide |
Satellite Symposium |
The Duet cervical barrier used continuously or pre-coitally for HIV prevention in Zimbabwean women: an acceptability and safety study |
Elizabeth T. Montgomery |
Vaginal Practices, Gel and Barrier Methods Use Among HIV Prevention Trial Participants in Southern Africa |
Arian van der Straten |
Dual Protection Polyurethane Intravaginal Rings for the Simultaneous Delivery of Levonorgestrel and UC781 |
Festo Damian |
Development of microbicide-releasing SILCS diaphragm |
Ian Major |
Vaginal Delivery of UC781 in Woman's Condom Capsules |
Lyndsay Ferguson |
Unmet family planning needs among HIV-positive participants screened for FEM-PrEP |
Jennifer Deese |
High uptake of non-barrier contraception by women before randomization into an HIV prevention trial in rural Kenya |
Kenneth Ngure |
Quick Dissolve Films as Drug Delivery Systems for Combination Microbicides |
Ayman Akil |
Design of an intravaginal ring for the simultaneous delivery of IQP-0528 and tenofovir |
Justin Clark |
Production and Preservation of Highly Viable Lactobacillus for Mucosal Delivery of Therapeutics in situ |
Qiang Xu |
Safety testing of silicone elastomer matrix vaginal rings containing UC781 and Tween 80 using Epivaginal (VEC-606) tissues |
Christopher McConoville |
Aptamers that neutralize Herpes Simplex Virus Type-2 as potential components of a multi virus microbicide |
Michael Moore |
Genital Secretions from HIV Infected Women Exhibit Decreased Activity Against HSV-2 |
Rebecca Pellett Madan |
Validity of Clinical Diagnosis of Vaginosis by Human Immunodeficiency Virus Infection Status |
Maria F. Gallo |
Combinin HIV prevention and contraceptive technologies |
Gustavo Doncel |
Functional Characteristics of the MucoCept Lactobacillus Strains upon their Adherence to Human Cervical and Vaginal Epithelial Cells |
Raina Fichorova |
New Prevention Technologies and sex workers: Protection for whom and at what price? |
Anna Forbes |
Posters
Printer friendly version (PDF)
Poster Title |
Presenter |
||||
Saving Lives and Resources through Multipurpose Prevention Technologies |
Bethany Young Holt |
||||
Development of Flavonoids for Use in a Combination Microbicide |
Charles E. Isaacs |
||||
RVFaH a Promising Protein Having Anti-STI and Anti-HIV Activities Identified in Rabbit Vaginal Fluid |
Mandar Patgaonkar |
||||
New Compound Derived from Seaweed with Antiretroviral Activity, with Prospects of Microbicidal Activity |
Claudio Cirne-Santos |
||||
Using Drug Combinations to Deign Effective Colorectal Microbicides: Where is the Limit? |
Carolina Herrera |
||||
Dual Protection Polyurethane Intravaginal Rings for the Simultaneous Delivery of Levonorgestrel and UC781 |
Festo Damian |
||||
Development of Silicone Vaginal Rings for Delivery of MIV-150 as a Microbicide |
Paul Mawson |
||||
Formulation Enhances Pyridmidinedione IQP-0528 Anti-HIV Activity in Polarized Cervical Explants |
Charlene Dezzutti |
||||
Design of an Intravaginal Ring for the Simultaneous Delivery of IQP-0528 and Tenofovir |
Justin Clark |
||||
Quick Dissolve Films as Drug Delivery Systems for Combination Microbicides |
Ayman Akil |
||||
Safety Testing of Silicone Elastomer Matrix Vaginal Rings Containing UC781 and Tween 80 Using Epivaginal (VEC-606) Tissues |
Christopher McConoville |
||||
Development of Microbicide-Releasing SILCS Diaphragm |
Ian Major |
||||
Vaginal Delivery of UC781 in Woman's Condom Capsules |
Lindsay Ferguson |
||||
Biophysical & Behavioral Acceptability of Microbicides |
Stephane Verguet |
||||
Bacterial Vaginosis (BV) Dynamics Among Women who Participated in a Four-Arm Microbicide Trial (HPTN 035) |
Taha Taha |
||||
A Validation Study of the Gen-Probe APTIMA Combo 2 (AC2) for Detecting Chlamydia Trachomatis and Neisseria Gonorrhea in Rectal Samples |
Lisa Cosentino |
||||
Hepatitis B, Hepititis C, and HIV-1 Coinfection in Two Selected Informal Urban Settlements in Nairobi, Kenya |
could not locate |
||||
Prevalence of Ulcerative Sexually Transmitted Infections (STIs) among HIV-Positive Women Clinic Attendees in a Nigerian Teaching Hospital |
Victoria Awolade |
||||
Unmet Family Planning Needs among HIV-Positive Participants Screened for FEM-PrEP |
Jennifer Deese |
||||
Good Intentions: Risk Factors for Unplanned Pregnancy in the U.S. Cohort of the HPTN 035 Microbicide Trial |
Sara Whittington |
||||
Pregnancy Incidence and Outcomes in HPTN 035 in Blantyre, Malawi: A Phase II/IIB Trial of the Vaginal Microbicides PRO 2000 and BufferGel |
Bonus Makanani |
||||
Pregnancy Rates in the DurbanSite of the MDP 301 Trial: Implications for VOICE and other PrEP Studies. |
Zakir Gaffoor |
||||
Targeting At Risk US Women for Trials of Cervical Barriers |
Erica Gollub |
||||
Effects of BV-Associated Bacteria and Sexual Intercourse on Vaginal Colonization with Probiotic Lactobacillus crispatus CTV-05 |
Benjamin Ngugi |
||||
Potential Impact of Circumcision on Herpes Simplex Virus Type 2 Prevalence Among Spouses in Five Northeastern States of India |
K Walia |
||||
